Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Rapid drinking water safety estimation in cities: Piloting a globally scalable method in Cochabamba, Bolivia.

Rocha-Melogno L, Yoo R, Broesicke O, Kallergis A, Garcia J, Herbas E, Torrez-Daza A, Johnson A, Boey D, Beard V, Frisbie SH, Murcott S, Brown J.

Sci Total Environ. 2019 Mar 1;654:1132-1145. doi: 10.1016/j.scitotenv.2018.11.119. Epub 2018 Nov 12.

PMID:
30841388
2.

Fatigue life of additively manufactured Ti6Al4V scaffolds under tension-tension, tension-compression and compression-compression fatigue load.

Lietaert K, Cutolo A, Boey D, Van Hooreweder B.

Sci Rep. 2018 Mar 21;8(1):4957. doi: 10.1038/s41598-018-23414-2.

3.

Continuous-flow C. elegans fluorescence expression analysis with real-time image processing through microfluidics.

Yan Y, Boey D, Ng LT, Gruber J, Bettiol A, Thakor NV, Chen CH.

Biosens Bioelectron. 2016 Mar 15;77:428-34. doi: 10.1016/j.bios.2015.09.045. Epub 2015 Sep 28.

PMID:
26452079
4.

Health Promotion Board-Ministry of Health Clinical Practice Guidelines: Falls Prevention among Older Adults Living in the Community.

Shyamala T, Wong SF, Andiappan A, Au Eong KG, Bakshi AB, Boey D, Chong TW, Eng HP, Ismail NH, Lau TC, Lim WY, Lim HW, Seong L, Wong WC, Yap KZ, Yudah S.

Singapore Med J. 2015 May;56(5):298-300; quiz 301. doi: 10.11622/smedj.2015073.

5.

Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice.

Nguyen AD, Slack K, Schwarzer C, Lee NJ, Boey D, Macia L, Yulyaningsih E, Enriquez RF, Zhang L, Lin S, Shi YC, Baldock PA, Herzog H, Sainsbury A.

Neuropeptides. 2014 Jun;48(3):143-51. doi: 10.1016/j.npep.2014.03.001. Epub 2014 Mar 14.

PMID:
24680736
6.

Synergistic attenuation of obesity by Y2- and Y4-receptor double knockout in ob/ob mice.

Lee NJ, Enriquez RF, Boey D, Lin S, Slack K, Baldock PA, Herzog H, Sainsbury A.

Nutrition. 2008 Sep;24(9):892-9. doi: 10.1016/j.nut.2008.06.019. Epub 2008 Jul 26.

PMID:
18662863
7.

PYY transgenic mice are protected against diet-induced and genetic obesity.

Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A.

Neuropeptides. 2008 Feb;42(1):19-30. doi: 10.1016/j.npep.2007.11.003. Epub 2007 Dec 27.

PMID:
18164057
8.

Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice.

Sainsbury A, Lin S, McNamara K, Slack K, Enriquez R, Lee NJ, Boey D, Smythe GA, Schwarzer C, Baldock P, Karl T, Lin EJ, Couzens M, Herzog H.

Mol Endocrinol. 2007 Jul;21(7):1722-35. Epub 2007 Apr 24.

PMID:
17456788
9.

Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways.

Lin S, Lin EJ, Boey D, Lee NJ, Slack K, During MJ, Sainsbury A, Herzog H.

Endocrinology. 2007 May;148(5):2056-65. Epub 2007 Feb 1.

PMID:
17272395
10.

The role of peptide YY in regulating glucose homeostasis.

Boey D, Sainsbury A, Herzog H.

Peptides. 2007 Feb;28(2):390-5. Epub 2007 Jan 8. Review.

PMID:
17210210
11.

Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes.

Boey D, Heilbronn L, Sainsbury A, Laybutt R, Kriketos A, Herzog H, Campbell LV.

Neuropeptides. 2006 Oct;40(5):317-24. Epub 2006 Oct 12.

PMID:
17045646
12.

Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.

Lin EJ, Sainsbury A, Lee NJ, Boey D, Couzens M, Enriquez R, Slack K, Bland R, During MJ, Herzog H.

Endocrinology. 2006 Nov;147(11):5094-101. Epub 2006 Jul 27.

PMID:
16873543
13.

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.

Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, Couzens M, Slack K, Dallmann R, Sainsbury A, Herzog H.

Diabetologia. 2006 Jun;49(6):1360-70. Epub 2006 Apr 21.

PMID:
16680491
14.

Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain.

Lin S, Boey D, Lee N, Schwarzer C, Sainsbury A, Herzog H.

Neuropeptides. 2006 Apr;40(2):115-23. Epub 2006 Jan 24.

PMID:
16439015
15.

Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice.

Sainsbury A, Bergen HT, Boey D, Bamming D, Cooney GJ, Lin S, Couzens M, Stroth N, Lee NJ, Lindner D, Singewald N, Karl T, Duffy L, Enriquez R, Slack K, Sperk G, Herzog H.

Diabetes. 2006 Jan;55(1):19-26.

16.

A fundamental bimodal role for neuropeptide Y1 receptor in the immune system.

Wheway J, Mackay CR, Newton RA, Sainsbury A, Boey D, Herzog H, Mackay F.

J Exp Med. 2005 Dec 5;202(11):1527-38.

17.

Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.

Baldock PA, Sainsbury A, Allison S, Lin EJ, Couzens M, Boey D, Enriquez R, During M, Herzog H, Gardiner EM.

J Bone Miner Res. 2005 Oct;20(10):1851-7. Epub 2005 May 31.

18.

Compensatory changes in [125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s).

Lin S, Boey D, Couzens M, Lee N, Sainsbury A, Herzog H.

Neuropeptides. 2005 Feb;39(1):21-8. Epub 2004 Nov 23.

PMID:
15627497
19.

NPY and Y receptors: lessons from transgenic and knockout models.

Lin S, Boey D, Herzog H.

Neuropeptides. 2004 Aug;38(4):189-200. Review.

PMID:
15337371
20.

Y1 receptors regulate aggressive behavior by modulating serotonin pathways.

Karl T, Lin S, Schwarzer C, Sainsbury A, Couzens M, Wittmann W, Boey D, von Hörsten S, Herzog H.

Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12742-7. Epub 2004 Aug 16.

Supplemental Content

Support Center